ClinicalTrials.gov
ClinicalTrials.gov Menu

International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01504152
Recruitment Status : Completed
First Posted : January 5, 2012
Last Update Posted : July 12, 2013
Sponsor:
Collaborator:
Weill Medical College of Cornell University
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

January 3, 2012
January 5, 2012
July 12, 2013
December 2011
July 2013   (Final data collection date for primary outcome measure)
prevalence of international travel [ Time Frame: 2 years ]
of the targeted patients Proportion of Hematopoietic Stem Cell Transplant (HSCT) patients who traveled internationally within two years after HSCT
Same as current
Complete list of historical versions of study NCT01504152 on ClinicalTrials.gov Archive Site
  • international travel was during a high-risk specific period [ Time Frame: 2 years ]
    Proportion of patients traveling to destinations that are at high risk areas for infections
  • patients that sought pre-travel health advice [ Time Frame: 2 years ]
    among those who traveled to high risk areas for infections
  • travelers that becomes ill and required medical attention [ Time Frame: 2 years ]
    during or after return from international travel.
Same as current
Not Provided
Not Provided
 
International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center
Survey to Assess International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center
The purpose of this study is to survey patients who underwent hematopoietic stem cell transplant (HSCT) to assess if they have traveled or not internationally after transplant. This information will help to improve the understanding of the needs for travel health strategies and interventions to provide healthy and safe travel to HSCT patients. The findings of this survey will also be used to develop travel health related interventions for patients living with cancer as well.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
Patients who received HSCT at MSKCC between 2005-2010 and were alive after the first year after HSCT.
Hematopoietic Stem Cell Transplant
Behavioral: questionnaire
The intervention is a self-administered questionnaire that is voluntarily completed by the subject. This questionnaire has been previously validated and demonstrated to be reproducible in English speaking travelers. The final version of the survey questionnaire consists of 49 questions.Patients who never traveled after HSCT will answer only eighteen questions related to their medical and HSCT history in addition to their demographics.
patients who received HSCT at MSKCC between 2005-2010
A self-administered patient questionnaire will be used to collect data that will assess the prevalence of international travel after HSCT and travel related morbidity and exposure risks among HSCT recipients.
Intervention: Behavioral: questionnaire
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
519
200
July 2013
July 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Hematopoietic Stem Cell Transplant (HSCT) recipients at MSKCC from 1/1/2005 to 12/31/2010.
  • Age at HSCT ≥ 18 years
  • Permanent mailing address in the United States of America

Exclusion Criteria:

  • Subject unable to fill the questionnaire due to language barriers.
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01504152
11-176
Not Provided
Not Provided
Not Provided
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
Principal Investigator: Monika Shah, MD Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
July 2013